Rani Therapeutics Prepares to Unveil Full 2025 Financial Performance

Alright, listen up, folks! For anyone keeping a close eye on Rani Therapeutics Holdings, Inc. (that's NASDAQ: RANI, by the way), there's a pretty important date coming up that you'll definitely want to mark on your calendars. The company is getting ready to pull back the curtain and share its financial performance for both the fourth quarter and the entirety of the 2025 fiscal year. It's always a big moment, isn't it, when a company shares how they've been doing?

So, when's this happening, you ask? Mark your calendars for Thursday, March 27, 2026. That's when Rani Therapeutics plans to host an investor conference call and webcast. You'll want to be ready to tune in around 4:30 PM Eastern Time (1:30 PM Pacific Time), because that's when all the details will start rolling out. It’s a chance for investors, analysts, and really anyone curious about the company's trajectory to hear directly from the source.

Now, how exactly do you get in on this? Well, they've made it quite convenient. If you prefer to listen and watch, a live webcast of the conference call will be available right on the investor relations section of the Rani Therapeutics website. Just head over to www.ranitherapeutics.com – you'll find it under "Investors" and then "Events & Presentations." Easy peasy!

For those who like the good old-fashioned phone call, you're covered too. You can dial in to the conference call. Just make sure you do it about 10 minutes before the scheduled start time. For U.S. participants, the number is (888) 886-7786. If you're calling from outside the U.S., you'll need (416) 764-8658. And when they ask for the conference ID, it’s 79844445. Simple enough, right?

And for those busy bees who just can't make it live – no worries at all! A webcast replay of the call will be made available shortly after it concludes. So, if you miss the initial broadcast, you can still catch up on all the financial insights at your leisure. It’ll be accessible for about 30 days following the event, giving you plenty of time to review. Ultimately, this call is all about transparency, helping everyone understand Rani Therapeutics' financial health and what lies ahead.